Patents by Inventor Eric Jnoff

Eric Jnoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydroisoquinoline derivatives
    Patent number: 10370355
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), wherein G represents a fused heterocyclic system selected from the groups represented by formula (G1), (G2), (G3), (G4), (G5), and (G6), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: August 6, 2019
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Ali Ates, Eric Jnoff, Laurent Provins, Anne Valade, Adrian Hall
  • Tetrahydroisoquinoline Derivatives
    Publication number: 20190106406
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), wherein G represents a fused heterocyclic system selected from the groups represented by formula (G1), (G2), (G3), (G4), (G5), and (G6), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: April 7, 2017
    Publication date: April 11, 2019
    Inventors: Ali Ates, Eric Jnoff, Laurent Provins, Anne Valade, Adrian Hall
  • Tetrahydroisoquinoline derivatives
    Patent number: 10105359
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: October 23, 2018
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Anne Valade, Eric Jnoff, Ali Ates, Pierre Burssens, David Skolc, Zara Sands, Benoit Mathieu
  • Isoindoline derivatives
    Patent number: 9975873
    Abstract: The present invention relates to isoindoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: May 22, 2018
    Assignee: UCB BIOPHARMA SPRL
    Inventors: David Skolc, Ali Ates, Eric Jnoff, Anne Valade, Benoit Mathieu, Zara Sands
  • Isoindoline Derivatives
    Publication number: 20170313677
    Abstract: The present invention relates to isoindoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: October 6, 2015
    Publication date: November 2, 2017
    Inventors: David Skolc, Ali Ates, Eric Jnoff, Anne Valade, Benoit Mathieu, Zara Sands
  • Tetrahydroisoquinoline Derivatives
    Publication number: 20170304292
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: October 6, 2015
    Publication date: October 26, 2017
    Inventors: Anne VALADE, Eric JNOFF, Ali ATES, Pierre BURSSENS, David SKOLC, Zara SANDS, Benoit MATHIEU
  • Compounds for enhancing the cognitive function
    Patent number: 9630948
    Abstract: The invention relates to 2-oxo-1-pyrrolidinyl triazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals for enhancing the cognitive function or to counteract cognitive decline.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: April 25, 2017
    Assignee: UCB Pharma, S.A.
    Inventors: Florian Montel, Eric Jnoff
  • Compounds for Enhancing the Cognitive Function
    Publication number: 20160185761
    Abstract: The invention relates to 2-oxo-1-pyrrolidinyl triazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals for enhancing the cognitive function or to counteract cognitive decline.
    Type: Application
    Filed: July 28, 2014
    Publication date: June 30, 2016
    Applicant: UCB Pharma, S.A.
    Inventors: Florian Montel, Eric Jnoff